Skip to main content
. 2022 May 25;13:756–767. doi: 10.18632/oncotarget.28231

Table 1. List of candidate genes for adenocarcinoma, squamous cell carcinoma and small cell carcinoma identified by excess of missense or nonsense mutations.

Histology Gene OBS missense EXP missense LOG(OBS/EXP)* OBS nonsense EXP nonsense LOG(OBS/EXP)*
Adeno TP53 145 1.88 5.62 24 0.16 5.14
Adeno KRAS 165 1.34 5.14 0 0.14
Adeno ARID1A 14 19.2 2.46 13 1.43 4.56
Adeno RBM10 12 7.89 1.35 17 0.71 3.71
Adeno RB1 12 6.61 2.15 12 0.74 3.61
Adeno STK11 28 4.12 1.43 26 0.30 3.60
Adeno ENHO 1 0.7 0.27 1 0.03 3.42
Adeno KRTAP19-2 1 0.43 0.68 2 0.06 3.36
Adeno KRTAP19-4 2 0.67 0.96 3 0.09 3.32
Adeno KRTAP6-2 10 0.57 3.25 0 0.07
Adeno BRAF 24 6.03 3.23 2 0.62 1.40
Adeno CD109 25 10.2 3.22 2 1.02 1.39
Adeno DEFB119 7 0.67 3.20 0 0.06
Adeno BICRA 8 15.6 0.77 4 0.70 3.18
Adeno FXYD7 1 0.68 0.43 1 0.03 3.16
Adeno ARID1B 23 21.41 3.16 3 1.63 2.55
Adeno GNG13 6 0.55 3.14 0 0.06
Adeno RPS29 1 0.58 0.64 1 0.03 3.14
Adeno HSPA12A 16 5.91 3.12 1 0.47 1.21
Adeno URGCP-MRPS24 2 1.08 0.67 3 0.11 3.10
Adeno DMXL1 27 21.7 3.09 4 2.19 2.08
Adeno DACT1 19 7.71 3.08 0 0.60
Adeno ATP5F1E 0 0.35 1 0.04 3.04
Adeno ADGRB1 18 15.8 3.04 1 1.05 1.52
Adeno CHST9 5 0.52 3.03 0 0.06
Adeno SATB2 19 6.25 3.01 3 0.55 2.35
Squamous CDKN2A 34 2.05 3.13 27 0.09 5.79
Squamous TP53 233 1.97 5.13 33 0.16 4.59
Squamous RASA1 12 10.05 2.20 9 0.87 3.67
Squamous SPANXN1 9 0.65 3.60 1 0.08 2.07
Squamous HLA-A 7 4.26 1.86 5 0.30 3.55
Squamous DEFB110 4 0.56 2.72 2 0.06 3.46
Squamous DEFB106A 1 0.55 0.90 1 0.03 3.43
Squamous KCNN2 24 5.85 3.39 1 0.41 1.26
Squamous SLC35G3 4 3.41 1.21 3 0.18 3.37
Squamous NEFM 24 9.55 3.37 2 1.12 1.46
Squamous LCE3D 4 1.05 1.89 2 0.06 3.35
Squamous BICRA 3 18.11 1.11 2 0.77 3.31
Squamous PASK 20 13.91 3.25 0 1.08
Squamous SEC61G 2 0.61 1.69 1 0.03 3.23
Squamous KRTAP21-1 8 0.78 3.20 1 0.05 2.68
Squamous TSHZ2 21 10.31 3.17 3 0.86 2.45
Squamous CPAMD8 17 21.31 3.16 2 1.40 2.46
Squamous ARID1A 14 22.9 1.72 8 1.60 3.09
Squamous KLB 19 10.41 3.06 0 0.86
Squamous FOXI2 2 3.93 0.41 2 0.19 3.06
Squamous CFH 29 11.51 3.06 6 1.33 2.41
Squamous H3F3A 1 1.51 -0.40 2 0.08 3.05
Squamous TMPRSS9 15 11.91 3.04 2 0.76 2.56
Squamous ITGB4 16 20.62 3.02 0 1.31
Squamous SAGE1 24 8.72 3.02 2 0.62 1.81
Squamous RPL39L 0 0.48 1 0.04 3.02
Small cell TP53 106 0.51 6.36 19 0.04 4.74
Small cell KIAA1211 31 3.14 3.92 1 0.29 0.39
Small cell SPHKAP 34 3.69 3.88 1 0.31 0.37
Small cell MUC12 26 12.05 3.77 1 0.82 1.05
Small cell POLR2K 3 0.11 3.60 0 0.01
Small cell BLCAP 0 0.19 2 0.01 3.43
Small cell KLK8 2 0.08 3.41 0 0.01
Small cell KRTAP23-1 3 0.13 3.33 0 0.01
Small cell FAM47C 22 2.62 3.33 1 0.19 0.52
Small cell OTOF 19 5.07 3.30 1 0.35 0.84
Small cell ZNF208 28 2.43 3.27 4 0.33 1.02
Small cell NPAS3 17 2.47 3.19 0 0.16
Small cell MYO16 17 4.28 3.15 1 0.33 0.70
Small cell CACNA1I 15 5.79 3.14 0 0.32
Small cell ALG10B 5 0.27 3.12 0 0.02
Small cell CD1E 5 0.28 3.05 1 0.02 1.71
Small cell PCDHA3 14 2.38 3.03 1 0.16 0.88
Small cell HMCN1 18 11.98 3.02 3 0.97 1.89

*The LOG ratios of the observed to the expected numbers of mutations are adjusted for the excess of silent mutations.